Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer
Conclusion: The combination of oncolytic adenovirus ZD55-SATB1 and chemotherapy provides a novel approach to effective therapy of prostate cancer.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Lijun Mao, Haiyuan Yu, Sai Ma, Ziyang Xu, Fukun Wei, Chunhua Yang, Junnian Zheng Tags: Research Paper Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Endocrine Therapy | Gene Therapy | Genetics | Prostate Cancer | Taxotere